论文部分内容阅读
More than 40%active pharmaceutical ingredients(API)and drug candidates identified through discovery screening programs are poorly water soluble.Conventional formulation of these molecules suffers from low bioavailability,poor pharmacokinetics,slow onset of action and other attributes,leading to poor patient compliance.